Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912051583> ?p ?o ?g. }
- W2912051583 endingPage "718" @default.
- W2912051583 startingPage "711" @default.
- W2912051583 abstract "Background: Cardiac reperfusion injury can have devastating consequences. Histone deacetylase (HDAC) inhibitors are potent cytoprotective agents, but their role in the prevention of cardiac injury remains ill-defined. Objective: We sought to determine the therapeutic potential of HDAC inhibitors in an in vitro model of cardiomyocyte hypoxia-reoxygenation (H/R). Method: H9c2 cardiomyocytes were subjected to H/R and treated with various classspecific and pan-HDAC inhibitors in equal concentrations (5µM). Biological activity of inhibitors was determined, as a proxy for concentration adequacy, by Western blot for acetylated histone H3 and α-tubulin. Cell viability and cytotoxicity were measured by methyl thiazolyl tetrazolium and lactate dehydrogenase assays, respectively. Mechanistic studies were performed to better define the effects of the most effective agent, Tubastatin-A (Tub-A), on the phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway effectors, and on the degree of autophagy. Results: All inhibitors acetylated well-known target proteins (histone H3 and α-tubulin), suggesting that concentrations were adequate to induce a biological effect. Improved cell viability and decreased cell cytotoxicity were noted in cardiomyocytes exposed to Tub-A, whereas the cytoprotective effects of other HDAC inhibitors were inconsistent. Pro-survival mediators in the PI3K/mTOR pathway were up-regulated and the degree of autophagy was significantly attenuated in cells that were treated with Tub-A. Conclusion: HDAC inhibitors improve cell viability in a model of cardiomyocyte H/R, with Class IIb inhibition (Tub-A) demonstrating superior cellular-level potency and effectiveness. This effect is, at least in part, related to an increased expression of prosurvival mediators and a decreased degree of autophagy. Keywords: Histone deacetylase, histone deacetylase inhibitors, hypoxia-reoxygenation, ischemia-reperfusion injury, cardiac injury." @default.
- W2912051583 created "2019-02-21" @default.
- W2912051583 creator A5031136904 @default.
- W2912051583 creator A5032642797 @default.
- W2912051583 creator A5037012634 @default.
- W2912051583 creator A5039348536 @default.
- W2912051583 creator A5051864517 @default.
- W2912051583 creator A5054859377 @default.
- W2912051583 creator A5056273184 @default.
- W2912051583 creator A5056658843 @default.
- W2912051583 creator A5058961918 @default.
- W2912051583 creator A5072420911 @default.
- W2912051583 creator A5072830760 @default.
- W2912051583 date "2019-03-13" @default.
- W2912051583 modified "2023-09-30" @default.
- W2912051583 title "Histone Deacetylase Inhibition Attenuates Cardiomyocyte Hypoxia-Reoxygenation Injury" @default.
- W2912051583 doi "https://doi.org/10.2174/1566524019666190208102729" @default.
- W2912051583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30734677" @default.
- W2912051583 hasPublicationYear "2019" @default.
- W2912051583 type Work @default.
- W2912051583 sameAs 2912051583 @default.
- W2912051583 citedByCount "8" @default.
- W2912051583 countsByYear W29120515832020 @default.
- W2912051583 countsByYear W29120515832021 @default.
- W2912051583 countsByYear W29120515832022 @default.
- W2912051583 countsByYear W29120515832023 @default.
- W2912051583 crossrefType "journal-article" @default.
- W2912051583 hasAuthorship W2912051583A5031136904 @default.
- W2912051583 hasAuthorship W2912051583A5032642797 @default.
- W2912051583 hasAuthorship W2912051583A5037012634 @default.
- W2912051583 hasAuthorship W2912051583A5039348536 @default.
- W2912051583 hasAuthorship W2912051583A5051864517 @default.
- W2912051583 hasAuthorship W2912051583A5054859377 @default.
- W2912051583 hasAuthorship W2912051583A5056273184 @default.
- W2912051583 hasAuthorship W2912051583A5056658843 @default.
- W2912051583 hasAuthorship W2912051583A5058961918 @default.
- W2912051583 hasAuthorship W2912051583A5072420911 @default.
- W2912051583 hasAuthorship W2912051583A5072830760 @default.
- W2912051583 hasConcept C104317684 @default.
- W2912051583 hasConcept C109316439 @default.
- W2912051583 hasConcept C119157956 @default.
- W2912051583 hasConcept C178790620 @default.
- W2912051583 hasConcept C181199279 @default.
- W2912051583 hasConcept C185592680 @default.
- W2912051583 hasConcept C190283241 @default.
- W2912051583 hasConcept C202751555 @default.
- W2912051583 hasConcept C203522944 @default.
- W2912051583 hasConcept C2776745794 @default.
- W2912051583 hasConcept C2777318727 @default.
- W2912051583 hasConcept C2778305200 @default.
- W2912051583 hasConcept C502942594 @default.
- W2912051583 hasConcept C53227056 @default.
- W2912051583 hasConcept C540031477 @default.
- W2912051583 hasConcept C55493867 @default.
- W2912051583 hasConcept C64927066 @default.
- W2912051583 hasConcept C7836513 @default.
- W2912051583 hasConcept C86554907 @default.
- W2912051583 hasConcept C86803240 @default.
- W2912051583 hasConcept C95444343 @default.
- W2912051583 hasConcept C98274493 @default.
- W2912051583 hasConceptScore W2912051583C104317684 @default.
- W2912051583 hasConceptScore W2912051583C109316439 @default.
- W2912051583 hasConceptScore W2912051583C119157956 @default.
- W2912051583 hasConceptScore W2912051583C178790620 @default.
- W2912051583 hasConceptScore W2912051583C181199279 @default.
- W2912051583 hasConceptScore W2912051583C185592680 @default.
- W2912051583 hasConceptScore W2912051583C190283241 @default.
- W2912051583 hasConceptScore W2912051583C202751555 @default.
- W2912051583 hasConceptScore W2912051583C203522944 @default.
- W2912051583 hasConceptScore W2912051583C2776745794 @default.
- W2912051583 hasConceptScore W2912051583C2777318727 @default.
- W2912051583 hasConceptScore W2912051583C2778305200 @default.
- W2912051583 hasConceptScore W2912051583C502942594 @default.
- W2912051583 hasConceptScore W2912051583C53227056 @default.
- W2912051583 hasConceptScore W2912051583C540031477 @default.
- W2912051583 hasConceptScore W2912051583C55493867 @default.
- W2912051583 hasConceptScore W2912051583C64927066 @default.
- W2912051583 hasConceptScore W2912051583C7836513 @default.
- W2912051583 hasConceptScore W2912051583C86554907 @default.
- W2912051583 hasConceptScore W2912051583C86803240 @default.
- W2912051583 hasConceptScore W2912051583C95444343 @default.
- W2912051583 hasConceptScore W2912051583C98274493 @default.
- W2912051583 hasIssue "10" @default.
- W2912051583 hasLocation W29120515831 @default.
- W2912051583 hasLocation W29120515832 @default.
- W2912051583 hasOpenAccess W2912051583 @default.
- W2912051583 hasPrimaryLocation W29120515831 @default.
- W2912051583 hasRelatedWork W2002636911 @default.
- W2912051583 hasRelatedWork W2020138518 @default.
- W2912051583 hasRelatedWork W2080968105 @default.
- W2912051583 hasRelatedWork W2141158999 @default.
- W2912051583 hasRelatedWork W2167141364 @default.
- W2912051583 hasRelatedWork W3002644491 @default.
- W2912051583 hasRelatedWork W3213993055 @default.
- W2912051583 hasRelatedWork W4247478287 @default.
- W2912051583 hasRelatedWork W4362594219 @default.
- W2912051583 hasRelatedWork W4380302347 @default.
- W2912051583 hasVolume "18" @default.